Senior Director of Enterprise AI Scaling and Innovation

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Overview For more than 140 years, Eli Lilly and Company has been committed to discovering and developing medicines that improve lives. Facing an accelerating pace of digital and AI transformation across healthcare, Lilly established Lilly Bengaluru India (LBI) as a strategic investment in future-ready capabilities: a globally connected, agile and innovation-driven organization, deeply attuned to the evolving needs of patients and healthcare systems. Within it, the Commercialization Capabilities organization enables Lilly's commercial teams worldwide across the end-to-end commercialization lifecycle, spanning five core focus areas: Business Intelligence & Analytics (BI&A), Global Operations Sales Organization (GOSO), Global Content Hub (GCH), Experience Activation (EXPA), and Commercial Learning Services (CLS). Lilly's enterprise AI agenda is delivered through NOVA (Next-generation Organizational Value through AI), the program through which AI initiatives are submitted, shaped, governed and scaled across GCCI, Medical Capabilities, GOSO and IBU Central. To further elevate LBI's strategic impact, we are seeking an accomplished AI leader to serve as Senior Director of Enterprise AI Scaling and Innovation. The role leads NOVA's global rollout and operational execution across these four organizations, working directly with their senior leaders to shape AI submissions into work that can credibly reach enterprise scale. Beyond NOVA, it drives Lilly's most critical cross-functional AI initiatives — including frontier programs such as SAGE, focused on agentification within brand launches — and maintains the enterprise's line of sight into a fast-moving external technology landscape. This is a deep-domain senior technical leadership role. The incumbent brings independent judgment on AI architecture, feasibility and cost-to-scale, and is the person the enterprise relies on to distinguish an AI initiative that will scale from one that will not. Success depends on technical credibility and the willingness to redirect or stop well-sponsored work that cannot reach production. This position reports to the Vice President and Global Head of LBI Commercialization Capabilities and operates with an enterprise mandate across the organizations NOVA serves.

NOVA Rollout & Operational Execution (~50%)  Own NOVA's rollout and operational execution across the four organizations, establishing it as the route through which enterprise AI work is shaped, prioritized, built and scaled.  Partner with senior leaders to shape AI submissions against the enterprise bar for scalability — value hypothesis, data readiness, architecture, cost-to-scale and path to production — reshaping what's unready and redirecting, consolidating or stopping what cannot clear it, so work reaches governed production rather than stalling as a proof of concept. Maintain the governance that makes speed safe (risk tiering, decision gates, responsible-AI standards, model and agent oversight), and raise the AI fluency of the leaders you advise so they sponsor AI work with realistic expectations of cost, risk and value. Own the value framework and KPIs that hold the NOVA portfolio accountable to realized impact, and help lead the organizational change, culture and talent development. Drive